This Plain Language Summary of Publication article (PLSP) from Future Oncology, the POLARIS clinical study investigated whether increasing the encorafenib dose alongside binimetinib would improve treatment effectiveness with manageable side effects for patients with advanced BRAF V600-mutant melanoma that has spread to the brain, a condition associated with poor outcomes.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis’ and was published in the Neuro-oncology Advances.

Visit Oxford Academic using the link to read the original article.